Tasmanian devil cathelicidins exhibit anticancer activity against Devil Facial Tumour Disease (DFTD) cellsSCIENTIFIC REPORTSIF3.92023-08-042OAAI
Genetic and genomic analyses of resistance to yersiniosis in Atlantic salmon (Salmo salar) assessed by tank challengeAQUACULTUREIF3.92023-02-011OAAI
A human adenovirus encoding IFN-γ can transduce Tasmanian devil facial tumour cells and upregulate MHC-IJOURNAL OF GENERAL VIROLOGYIF4.32022-11-287OA
Challenges of an Emerging Disease: The Evolving Approach to Diagnosing Devil Facial Tumour DiseasePATHOGENSIF3.32021-12-281OAAI
Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trialsIMMUNOLOGY AND CELL BIOLOGYIF32021-03-216PREAI
A novel system to map protein interactions reveals evolutionarily conserved immune evasion pathways on transmissible cancersSCIENCE ADVANCESIF12.52020-07-0316OAAI
An oral bait vaccination approach for the Tasmanian devil facial tumor diseasesEXPERT REVIEW OF VACCINESIF4.82020-01-2325OA
Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii)CELLULAR AND MOLECULAR LIFE SCIENCESIF6.22020-01-0313OAAI
Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii)CELLULAR AND MOLECULAR LIFE SCIENCESIF6.22019-08-0222OAAI
Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild ReleaseFRONTIERS IN IMMUNOLOGYIF5.92018-02-1929OAAI